ERK-IN-4
CAS No. 1049738-54-6
ERK-IN-4( —— )
Catalog No. M34872 CAS No. 1049738-54-6
ERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 101 | In Stock |
|
| 2MG | 52 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 231 | In Stock |
|
| 50MG | 334 | In Stock |
|
| 100MG | 499 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameERK-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction.
-
DescriptionERK-IN-4 is an ERK inhibitor binds preferentially to ERK2 with a Kd of 5 μM. ERK-IN-4 specificity inhibits ERK Rsk-1 and Elk-1 phosphorylation. ERK-IN-4has little effect on ERK protein phosphorylation by its upstream activator MEK1/2.
-
In VitroCell Proliferation AssayCell Line:HeLa, A549, or SUM-159 cells Concentration:10 μM, 20 μM, 30 μM, 40 μM, 150 μM for A549, or SUM-159 cells; 25 μM, 50 μM, 75 μM for HeLa cells Incubation Time:10 days Result:Completely inhibited cell proliferation.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1049738-54-6
-
Formula Weight328.814
-
Molecular FormulaC14H17ClN2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (76.03 mM; Ultrasonic (<80°C)
-
SMILESCl.O=C1SC(=CC2=CC=C(OCC)C=C2)C(=O)N1CCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chad N Hancock, et al. Identification of novel extracellular signal-regulated kinase docking domain inhibitors. J Med Chem. 2005 Jul 14;48(14):4586-95.?
molnova catalog
related products
-
ASTX029
ASTX029 is a selective and orally bioavailable extracellular signal-regulated kinases 1 and 2 (ERK 1/2) inhibitor, with potential antineoplastic activity.
-
GSK2656157
GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay.
-
CAFESTOL
CAFESTOL is a ERK inhibitor for AP-1-targeted activity against PGE2 production and the mRNA expression of cyclooxygenase (COX)-2 in LPS-activated RAW264.7 cells.?Cafestol has strong inhibitory activity on PGE2 production by suppressing the NF-kB activation pathway.
Cart
sales@molnova.com